Fluphenazine Enanthate serves as a medication for the treatment of tardive dyskinesia (TD) in monkeys. Fluphenazine Enanthate also functions as a medication for the antipsychotics study on human prolactin levels. Fluphenazine Enanthate reduces the blood pressure of pentobarbital Na anesthetized dogs, reduces heart rate in anesthetized dogs, and increases coronary blood flow and femoral blood flow in anesthetized dogs enhancing cardiovascular functions.
